Nouscom names new CMO and VP
12 September 2022 -

Nouscom, a clinical stage immuno-oncology company, announced on Friday that it has named Sven Gogov, MD as its new chief medical officer (CMO) and Maria Arce-Tomas, PhD as vice president, head of Regulatory Affairs.

Gogov has more than 15 years of pharmaceutical oncology experience and regulatory interactions. He has served as vice president Clinical Development of the company, and held the position of executive director, Global Immuno-Oncology at Incyte. He has also held various senior clinical development positions in oncology at Novartis and OSI Pharmaceuticals.

Arce-Tomas holds senior corporate leadership positions at various pharmaceutical and biotechnology companies including Novo Nordisk, GE Healthcare, Takeda, Abbott, Norgine and GSK. She has served as Global Head of Regulatory Affairs at PharmaMar Group.